ABSTRACT
Background Climate change and urbanization are rapidly increasing human exposure to extreme ambient temperatures, yet few studies have examined the impact of temperature on mortality across Latin America, where 80% of residents live in urban areas.
Methods We used distributed lag nonlinear conditional Poisson models to estimate city-specific associations between daily temperatures above (“heat”) and below (“cold”) each city-specific minimum mortality temperature and all-cause mortality, overall and stratified by age and cause of death. We estimated the percentage of total deaths attributable to heat or cold (excess death fraction [EDF]) and the difference in mortality per 1°C higher daily mean temperature above the 95th percentile of observed daily temperature.
Results We analyzed data from 326 cities in nine Latin American countries between 2002-2015, representing 15,431,532 deaths from 249 million residents. The EDF of total deaths from heat was 0.67% (95% confidence interval [CI] 0.58%, 0.74%), and from cold was 5.09% (95% CI 4.64%, 5.47%). EDFs from heat and cold were particularly high among individuals aged 65+ years (0.81% [95% CI 0.75%, 0.86%] and 6.82% [95% CI 6.41%, 7.18%], respectively). The relative risk of death per 1°C increase above the city-specific 95th percentile daily temperature was 1.057 (95% CI 1.046, 1.067).
Conclusions In Latin American cities, a substantial proportion of deaths are attributable to non-optimal ambient temperatures. Older populations are particularly vulnerable. Marginal increases in observed hot temperatures are associated with steep increases in mortality risk. Projected increases in temperature from climate change may have a substantial impact on mortality.
SIGNIFICANCE STATEMENT Latin America has a large population at risk of urban heat exposure, yet little is known about the linkages between ambient temperature and health in the region. We analyzed over 15 million deaths in 326 Latin American cities to characterize the relationship between ambient temperature and mortality, overall and by age and cause of death. We found that 5.75% of all deaths are associated with non-optimal temperatures, older individuals are particularly vulnerable, and cardiorespiratory deaths are especially affected. A single degree increase (1°C) in daily temperature was associated with a 5.7% higher mortality among hot days, suggesting that projected increases in temperature from climate change may have a substantial impact on mortality.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was financially supported by the Wellcome Trust [216029/Z/19/Z], [205177/Z/16/Z].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Vital registration and population data for Brazil, Chile, and Mexico were downloaded from publicly available repositories from statistical agencies in each country. Vital registration and population data for Argentina, Costa Rica, El Salvador, Guatemala, Panama and Peru were obtained directly from statistical agencies in each country. A link to these agency websites can be accessed via https://drexel.edu/lac/data-evidence/data-acknowledgements/.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵§ Joint senior authors
Data Availability
Vital registration and population data for Brazil, Chile, and Mexico were downloaded from publicly available repositories from statistical agencies in each country. Vital registration and population data for Argentina, Costa Rica, El Salvador, Guatemala, Panama and Peru were obtained directly from statistical agencies in each country. A link to these agency websites can be accessed via https://drexel.edu/lac/data-evidence/data-acknowledgements/.
